These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1486982)

  • 1. Enhanced stability of an immunotoxin made with abrin A chain and a hindered disulphide cross-linker.
    Cumber A; Wawrzynczak E
    Biochem Soc Trans; 1992 Nov; 20(4):312S. PubMed ID: 1486982
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
    Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
    Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
    Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
    Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of cytotoxic antibody-toxin conjugates.
    Cumber AJ; Wawrzynczak EJ
    Methods Mol Biol; 1998; 80():135-44. PubMed ID: 9664370
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective cytotoxic effects of immunotoxin--monoclonal anti-AFP-abrin-A chain conjugate on several human hepatoma cell lines.
    Chow LP; Chang KH; Lin JY
    Biochem Int; 1990 Oct; 22(1):95-102. PubMed ID: 1704234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiol-containing cross-linking agent with enhanced steric hindrance.
    Greenfield L; Bloch W; Moreland M
    Bioconjug Chem; 1990; 1(6):400-10. PubMed ID: 2129154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
    Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
    Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New coupling reagents for the preparation of disulfide cross-linked conjugates with increased stability.
    Arpicco S; Dosio F; Brusa P; Crosasso P; Cattel L
    Bioconjug Chem; 1997; 8(3):327-37. PubMed ID: 9177838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.
    Thorpe PE; Wallace PM; Knowles PP; Relf MG; Brown AN; Watson GJ; Knyba RE; Wawrzynczak EJ; Blakey DC
    Cancer Res; 1987 Nov; 47(22):5924-31. PubMed ID: 3499221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
    Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
    J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
    Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative ion fragmentations of disulfide-containing cross-linking reagents are competitive with aspartic acid side-chain-induced cleavages.
    Calabrese AN; Wang T; Bowie JH; Pukala TL
    Rapid Commun Mass Spectrom; 2013 Jan; 27(1):238-48. PubMed ID: 23239338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the domain structure of abrin-a by tryptic digestion.
    Lin SH; Chow LP; Chen YL; Liaw YC; Chen JK; Lin JY
    Eur J Biochem; 1996 Sep; 240(3):564-9. PubMed ID: 8856055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stability.
    Goff DA; Carroll SF
    Bioconjug Chem; 1990; 1(6):381-6. PubMed ID: 2099186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.
    Wawrzynczak EJ; Zangemeister-Wittke U; Waibel R; Henry RV; Parnell GD; Cumber AJ; Jones M; Stahel RA
    Br J Cancer; 1992 Aug; 66(2):361-6. PubMed ID: 1323991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
    Rosenblum MG; Marks JW; Cheung LH
    Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemical linkage upon the stability and cytotoxic activity of A chain immunotoxins.
    Wawrzynczak EJ; Thorpe PE
    Cancer Treat Res; 1988; 37():239-51. PubMed ID: 2908627
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators.
    Teodoro R; Faintuch BL; Núñez EG; Queiróz RG
    Nucl Med Biol; 2011 Jan; 38(1):113-20. PubMed ID: 21220134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the in vitro and in vivo activities of conjugates of anti-mouse lymphocyte globulin and abrin.
    Edwards DC; Ross WC; Cumber AJ; McIntosh D; Smith A; Thorpe PE; Brown A; Williams RH; Davies AJ
    Biochim Biophys Acta; 1982 Aug; 717(2):272-7. PubMed ID: 7115768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of an anti-CD19 single-chain Fv immunotoxin composed of C-terminal disulfide-linked dgRTA.
    Wang D; Li Q; Hudson W; Berven E; Uckun F; Kersey JH
    Bioconjug Chem; 1997; 8(6):878-84. PubMed ID: 9404661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.